The public health playbook: ideas for challenging the corporate playbook.
Journal
The Lancet. Global health
ISSN: 2214-109X
Titre abrégé: Lancet Glob Health
Pays: England
ID NLM: 101613665
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
received:
18
11
2021
revised:
15
03
2022
accepted:
31
03
2022
pubmed:
28
5
2022
medline:
22
6
2022
entrez:
27
5
2022
Statut:
ppublish
Résumé
Many commercial actors use a range of coordinated and sophisticated strategies to protect business interests-their corporate playbook-but many of these strategies come at the expense of public health. To counter this corporate playbook and advance health and wellbeing, public health actors need to develop, refine, and modernise their own set of strategies, to create a public health playbook. In this Viewpoint, we seek to consolidate thinking around how public health can counter and proactively minimise powerful commercial influences. We propose an initial eight strategies for this public health playbook: expand public health training and coalitions, increase public sector resources, link with and learn from social movements to foster collective solidarity, protect public health advocates from industry threats, develop and implement rigorous conflict of interest safeguards, monitor and expose corporate activities, debunk corporate arguments, and leverage diverse commercial interests. This set of strategies seeks to amplify inherent assets of the public health community and create opportunities to explicitly counter the corporate playbook. These strategies are not exhaustive, and our aim is to provoke further discussion on and exploration of this topic. TRANSLATION: For the Spanish translation of this paper see Supplementary Materials section.
Identifiants
pubmed: 35623376
pii: S2214-109X(22)00185-1
doi: 10.1016/S2214-109X(22)00185-1
pmc: PMC9197808
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1067-e1072Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Informations de copyright
Copyright © 2022 World Health Organization; licensee Elsevier. This is an Open Access article published under the CC BY-NC-ND 3.0 IGO license which permits users to download and share the article for non-commercial purposes, so long as the article is reproduced in the whole without changes, and provided the original source is properly cited. This article shall not be used or reproduced in association with the promotion of commercial products, services or any entity. There should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.
Déclaration de conflit d'intérêts
Declaration of interests We declare no competing interests.
Références
Lancet Glob Health. 2020 Mar;8(3):e329-e330
pubmed: 32087164
Am J Public Health. 2006 Nov;96(11):2048-54
pubmed: 17018823
Int J Health Policy Manag. 2021 Dec 01;10(12):845-856
pubmed: 34634883
Global Health. 2020 Aug 17;16(1):74
pubmed: 32807183
BMJ Open. 2020 Jul 19;10(7):e034082
pubmed: 32690498
Public Health Nutr. 2020 Feb;23(3):564-575
pubmed: 31397246
Am J Public Health. 2017 Jul;107(7):1047-1049
pubmed: 28590869
Global Health. 2021 Jan 5;17(1):5
pubmed: 33402166
Acad Med. 2010 Jan;85(1):63-7
pubmed: 20042825
BMJ Glob Health. 2021 Feb;6(2):
pubmed: 33593758
Lancet. 2008 Nov 8;372(9650):1661-9
pubmed: 18994664
Eur J Public Health. 2021 Oct 11;31(4):672-673
pubmed: 34137787
Public Health Nutr. 2020 Aug;23(11):2032-2040
pubmed: 32416734
Milbank Q. 2009 Mar;87(1):259-94
pubmed: 19298423
Lancet. 2018 Jun 16;391(10138):2400-2401
pubmed: 29858115
Tob Control. 2018 Mar;27(2):185-194
pubmed: 28336521
Health Promot Int. 2020 Aug 1;35(4):877-887
pubmed: 31504470
Lancet Glob Health. 2021 Aug;9(8):e1055-e1056
pubmed: 34297953
Soc Sci Med. 2015 Mar;128:316-26
pubmed: 25577953
Am J Public Health. 2021 Dec;111(12):2202-2211
pubmed: 34878875